These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29487319)

  • 1. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1.
    Woodside DG; Tanifum EA; Ghaghada KB; Biediger RJ; Caivano AR; Starosolski ZA; Khounlo S; Bhayana S; Abbasi S; Craft JW; Maxwell DS; Patel C; Stupin IV; Bakthavatsalam D; Market RV; Willerson JT; Dixon RAF; Vanderslice P; Annapragada AV
    Sci Rep; 2018 Feb; 8(1):3733. PubMed ID: 29487319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque.
    van Bochove GS; Paulis LE; Segers D; Mulder WJ; Krams R; Nicolay K; Strijkers GJ
    Contrast Media Mol Imaging; 2011; 6(1):35-45. PubMed ID: 20882509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
    Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
    Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
    Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
    Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques.
    Majmudar MD; Yoo J; Keliher EJ; Truelove JJ; Iwamoto Y; Sena B; Dutta P; Borodovsky A; Fitzgerald K; Di Carli MF; Libby P; Anderson DG; Swirski FK; Weissleder R; Nahrendorf M
    Circ Res; 2013 Mar; 112(5):755-61. PubMed ID: 23300273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Reimann C; Brangsch J; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Hamm B; Botnar RM; Makowski MR
    Sci Rep; 2019 Sep; 9(1):13827. PubMed ID: 31554825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
    Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 64Cu-Labeled Divalent Cystine Knot Peptide for Imaging Carotid Atherosclerotic Plaques.
    Jiang L; Tu Y; Kimura RH; Habte F; Chen H; Cheng K; Shi H; Gambhir SS; Cheng Z
    J Nucl Med; 2015 Jun; 56(6):939-44. PubMed ID: 25908832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scavenger receptor-AI-targeted ultrasmall gold nanoclusters facilitate in vivo MR and ex vivo fluorescence dual-modality visualization of vulnerable atherosclerotic plaques.
    Wang J; Wu M; Chang J; Li L; Guo Q; Hao J; Peng Q; Zhang B; Zhang X; Li X
    Nanomedicine; 2019 Jul; 19():81-94. PubMed ID: 31028886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
    Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
    Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
    Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.
    Li Y; Liu J; Huang JW; Song JC; Ma ZL; Shi HB
    Acta Radiol; 2018 Dec; 59(12):1431-1437. PubMed ID: 29566551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque.
    Rashid I; Maghzal GJ; Chen YC; Cheng D; Talib J; Newington D; Ren M; Vajandar SK; Searle A; Maluenda A; Lindstedt EL; Jabbour A; Kettle AJ; Bongers A; Power C; Michaëlsson E; Peter K; Stocker R
    Eur Heart J; 2018 Sep; 39(35):3301-3310. PubMed ID: 30219874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.
    Almer G; Summers KL; Scheicher B; Kellner J; Stelzer I; Leitinger G; Gries A; Prassl R; Zimmer A; Mangge H
    Int J Nanomedicine; 2014; 9():4211-22. PubMed ID: 25214785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging visualization of vulnerable atherosclerotic plaques at the brachiocephalic artery of apolipoprotein E knockout mice by the blood-pool contrast agent B22956/1.
    Parolini C; Busnelli M; Ganzetti GS; Dellera F; Manzini S; Scanziani E; Johnson JL; Sirtori CR; Chiesa G
    Mol Imaging; 2014; 13():. PubMed ID: 24825406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of targeted magnetic resonance imaging on visualizing tenascin-C expression in atherosclerosis plaque in high-fat diet fed ApoE(-/-) mice].
    Meng H; Ma ZL; Yan HL; Chen XX; Shang SA; Yu J; Song JC; Shi HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):342-7. PubMed ID: 27112614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.